Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Filings indexed 1,245 across all filing types
Latest filing 2022-06-08 Major Shareholding Noti…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs
Major Shareholding Notification Classification · 100% confidence The document is a disclosure pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of shares by an acquirer in Bliss GVS Pharma Limited, including the number of shares acquired, percentage of shareholding before and after acquisition, mode of acquisition, and dates. This type of document is a notification of a change in significant share ownership levels, which fits the definition of a Major Shareholding Notification (MRQ). The document is not a full financial report, earnings release, or management report, but a regulatory disclosure about share acquisition.
2022-06-08 English
Newspaper Advertisements
AGM Information Classification · 95% confidence The document is a notice addressed to stock exchanges regarding the publication of a newspaper advertisement for the 37th Annual General Meeting (AGM) of the company. It includes details about the AGM date, e-voting, and book closure information. The document references compliance with SEBI regulations related to disclosures for listed companies. The content is primarily about informing the exchanges and public about the AGM notice publication rather than the AGM materials themselves or the results of the meeting. The document length is about 15,000 characters, but the content is an announcement of the AGM notice publication, not the AGM presentation or minutes. Therefore, it fits best under the category of AGM Information (AGM-R) as it relates to the AGM notice and related information shared with shareholders and the public.
2022-06-07 English
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements pertaining to Notice ....
AGM Information Classification · 95% confidence The document is a notice addressed to stock exchanges regarding the publication of a newspaper advertisement for the 37th Annual General Meeting (AGM) of the company. It includes details about the AGM date, e-voting, and book closure information. The content is primarily an announcement of the AGM notice publication rather than the AGM materials themselves. There is no detailed presentation or report content, just a formal communication about the notice advertisement. Therefore, this fits the category of AGM Information (AGM-R).
2022-06-07 English
Record Date
Regulatory Filings Classification · 90% confidence The document is extremely short (326 characters) and appears to be a brief communication addressed to stock exchanges (NSE and BSE) with no substantive content or financial data. It lacks any detailed report, financial statements, or announcements of corporate actions. Given its brevity and format, it is likely a regulatory filing or a simple notice rather than a full report or announcement. Therefore, it fits best under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2022-06-06 English
Annual General Meeting
Annual Report Classification · 100% confidence The document is a communication from Bliss GVS Pharma Ltd dated June 6, 2022, addressed to stock exchanges, containing the Annual Report for the financial year 2021-22, notice convening the 37th Annual General Meeting (AGM), and intimation of record date for dividend. The text explicitly mentions the Annual Report for FY 2021-22 is enclosed and available on the company's website. The document includes detailed sections such as Corporate Overview, Statutory Section, Financial Section, Managing Director's perspective, financial performance, and business review, indicating it is the full Annual Report. The length is about 15,000 characters, which is consistent with a full report rather than a brief announcement. The presence of detailed financial data, management discussion, auditor's report, and corporate governance confirms this is the actual Annual Report document, not just an announcement or notice. Therefore, the correct classification is Annual Report (10-K).
2022-06-06 English
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and in continuation to our ....
Notice of Dividend Amount Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the fixation of a Record Date for determining entitlement to the Final Dividend for the financial year ended March 31, 2022. It mentions the payment of dividend subject to approval at the upcoming AGM. The content is an announcement about dividend-related dates and not the dividend report itself. The document length is short (1938 characters), and it serves as an official notification of dividend-related information. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2022-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.